Coral Laboratories Profit & Loss Annual

BSE: 524506 | NSE: - | ISIN: INE683E01017 | Sector: Biotechnology & Drugs

769.00 -10.70 (-1.37%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	83.66	78.12	75.61	96.57
Total Revenue	83.66	78.12	75.61	96.57
Costof Revenue Total	37.25	52.27	45.12	55.78
Gross Profit	46.41	25.85	30.49	40.79
Selling/ General/ Admin Expenses Total	11.20	18.47	18.36	20.89
Depreciation/ Amortization	1.98	2.16	1.97	1.96
Unusual Expense( Income)	0.16	-0.04	-0.96	-0.02
Other Operating Expenses Total	18.98	3.13	3.54	3.63
Total Operating Expense	69.56	76.01	68.05	82.27
Operating Income	14.10	2.11	7.56	14.30
Interest Inc( Exp) Net- Non- Op Total	0.00	46.84	30.15	19.19
Other Net	6.63	1.43	1.28	1.39
Net Income Before Taxes	20.73	8.23	11.86	17.61
Provisionfor Income Taxes	4.94	1.78	2.81	4.06
Net Income After Taxes	15.79	6.45	9.05	13.55
Net Income Before Extra Items	15.79	6.45	9.05	13.55
Net Income	15.79	6.45	9.05	13.55
Total Adjustmentsto Net Income	0.00	-	-	0.00
Income Availableto Com Excl Extra Ord	15.79	6.45	9.05	13.55
Income Availableto Com Incl Extra Ord	15.79	6.45	9.05	13.55
Diluted Net Income	15.79	6.45	9.05	13.55
Diluted Weighted Average Shares	0.36	0.36	0.36	0.36
Diluted EPS Excluding Extra Ord Items	44.19	18.04	25.32	37.94
Diluted Normalized EPS	44.54	17.96	23.27	37.90
Interest Exp( Inc) Net- Operating Total	-	0.22	0.22	0.22